• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

GSK’s Shingrix showed to offer ten years of shingles protection in study

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 20, 2022 at 11:02: AM
via GSK has reported positive interim data from the ZOSTER-049 extension study, where its recombinant, adjuvanted Zoster vaccine, Shingrix, showed to offer a minimum of ten years of protection against shingles (herpes zoster) following preliminary vaccination.

article source
 




Top Bottom
Back
Quote